On January 7, 2021 Rakuten Medical, Inc. (RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox, reported that it will present at the 39th Annual J.P. Morgan Healthcare Conference being held virtually January 11-14, 2021 (Press release, Rakuten Medical, JAN 7, 2021, View Source [SID1234573661]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Rakuten Medical’s Chairman and CEO, Hiroshi "Mickey" Mikitani, is scheduled to present virtually at approximately 4:30 a.m. PST, Monday, January 11. A live audio webcast of the presentation can be accessed by following this link. Following the completion of the presentation, a full audio recording will be available in the News section of the Rakuten Medical, Inc website at www.rakuten-med.com and will be archived in this location for 30 days.